Efficacy and safety analysis of donafenib combined with transarterial chemoembolization in the treatment of unresectable hepatocellular carcinoma: A prospective, single-arm, single center, phase II clinical study.

被引：0
|
作者：
Li, Jinpeng
Chen, Hua
Song, Jinlong
机构：
[1] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Jinan, Peoples R China
[2] Shandong First Med Univ & Shandong Acad Med Sci, Shandong Canc Hosp & Inst, Intervent Ward One, Jinan, Shandong, Peoples R China
[3] Shandong Canc Hosp & Inst, Jinan, Shandong, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16134
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study
    Kwon, Joon Ho
    Kim, Gyoung Min
    Han, Kichang
    Won, Jong Yun
    Kim, Man Deuk
    Lee, Do Yun
    Lee, Junhyung
    Choi, Woosun
    Kim, Yong Seek
    Kim, Do Young
    Han, Kwang-Hyub
    CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 2018, 41 (03) : 459 - 465
  • [22] Safety and Efficacy of Transarterial Radioembolization Combined with Chemoembolization for Bilobar Hepatocellular Carcinoma: A Single-Center Retrospective Study
    Joon Ho Kwon
    Gyoung Min Kim
    Kichang Han
    Jong Yun Won
    Man Deuk Kim
    Do Yun Lee
    Junhyung Lee
    Woosun Choi
    Yong Seek Kim
    Do Young Kim
    Kwang-Hyub Han
    CardioVascular and Interventional Radiology, 2018, 41 : 459 - 465
  • [23] Efficacy and safety of transcatheter arterial chemoembolization-lenvatinib sequential therapy for patients with unresectable hepatocellular carcinoma: a single-arm clinical study
    Chen, Ruiqing
    Li, Lingbing
    Li, Ye
    Song, Ke
    Shen, Chenyu
    Ma, Pengkai
    Wang, Zhijun
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 13 (03) : 1367 - 1375
  • [24] Efficacy and Safety of Transarterial Chemoembolization Combined With Anlotinib for Unresectable Hepatocellular Carcinoma: A Retrospective Study
    Guo, Wenbo
    Chen, Song
    Wu, Zhiqiang
    Zhuang, Wenquan
    Yang, Jianyong
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2020, 19
  • [25] TACE combined with tislelizumab and TKI as a conversion therapy in initial unresectable hepatocellular carcinoma (uHCC): A prospective single-arm phase II clinical study
    Liu, S.
    Lin, S.
    Luo, H.
    Luo, J.
    Mo, W.
    Zhong, J-H.
    ANNALS OF ONCOLOGY, 2024, 35 : S78 - S79
  • [26] Safety and Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitors for Unresectable Hepatocellular Carcinoma: A Single Center Experience
    Pan, Xian
    Wu, Shao-Jie
    Tang, Yi
    Zhou, Yan-Feng
    Luo, Jie-Wei
    Fang, Zhu-Ting
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2023, 10 : 883 - 892
  • [27] Safety, efficacy, and survival of different transarterial chemoembolization techniques in the management of unresectable hepatocellular carcinoma: a comparative single-center analysis
    Schindler, Philipp
    Kaldewey, Daniel
    Rennebaum, Florian
    Trebicka, Jonel
    Pascher, Andreas
    Wildgruber, Moritz
    Koehler, Michael
    Masthoff, Max
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (05)
  • [28] Efficacy and safety of transarterial therapy combined with donafenib plus immune checkpoint inhibitors for unresectable hepatocellular carcinoma: A multicenter retrospective study.
    Shang, Changzhen
    Zhong, Jinyi
    Luo, Xuan
    Zhang, Bo
    Chen, Huanwei
    Wang, Fengjie
    Jiang, Xiaofeng
    Cao, Liangqi
    Shen, Shun-Li
    Chen, Yajin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [29] THE SAFETY AND EFFICACY OF SORAFENIB COMBINED WITH TRANSARTERIAL CHEMOEMBOLIZATION FOR PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA
    Shao, W.
    Cong, N.
    Song, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 161 - 161
  • [30] Toripalimab in combination with Anlotinib for unresectable hepatocellular carcinoma after SBRT: A prospective, single-arm, single-center clinical study
    Chen, Yongbiao
    Hong, Hanyin
    Fang, Wenzheng
    Zhang, Xia
    Luo, Huachun
    Chen, Zhijian
    Yu, Jianda
    Fan, Weiqiang
    Chi, Xiaobin
    Peng, Yonghai
    FRONTIERS IN ONCOLOGY, 2023, 13
12345